Aayush Wellness product launch announcements

Product LaunchAayush Wellness Ltd AAYUSHAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Aayush Wellness Product Launch

Aayush Wellness Limited has launched 'Aayush Calcium Vitamin Tablets' to expand its nutraceutical portfolio. The new product targets the growing bone and joint health market segment.

Product LaunchAayush Wellness Ltd AAYUSHAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Aayush Wellness Product Launch

Aayush Wellness Limited has launched its new Lung Care Tablets, expanding its preventive healthcare portfolio. This product targets consumers concerned about respiratory health.

Product LaunchAayush Wellness Ltd AAYUSHAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Aayush Wellness Product Launch

Aayush Wellness launched Aayush Dia Shield Tablets, entering India's ₹36,656 Crore metabolic health market. The herbal supplement targets 230 million Indians currently affected by diabetes.

Value

₹36.66 Cr

Product LaunchAayush Wellness Ltd AAYUSHAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Aayush Wellness Product Launch

Aayush Wellness Limited has launched 'Liver Detox Tablets' to address the growing demand for preventive liver health solutions in India. The herbal formulation targets lifestyle-related liver disorders and is available on the company's official website. This launch aligns with the company's strategy to expand its condition-led preventive healthcare portfolio in the $18 billion nutraceutical market.